Skylands Capital’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,650
| Closed | -$383K | – | 156 |
|
|
2024
Q4 | $383K | Sell |
1,650
-1,750
| -51% | -$402K | 0.05% | 123 |
|
|
2024
Q3 | $750K | Sell |
3,400
-1,150
| -25% | -$238K | 0.1% | 110 |
|
|
2024
Q2 | $895K | Sell |
4,550
-125
| -3% | -$25.8K | 0.13% | 103 |
|
|
2024
Q1 | $1.01M | Sell |
4,675
-4,575
| -49% | -$961K | 0.14% | 100 |
|
|
2023
Q4 | $1.95M | Sell |
9,250
-500
| -5% | -$107K | 0.29% | 77 |
|
|
2023
Q3 | $1.95M | Sell |
9,750
-700
| -7% | -$139K | 0.3% | 75 |
|
|
2023
Q2 | $1.94M | Sell |
10,450
-150
| -1% | -$27.7K | 0.28% | 72 |
|
|
2023
Q1 | $2.03M | Sell |
10,600
-3,600
| -25% | -$651K | 0.3% | 66 |
|
|
2022
Q4 | $2.39M | Buy |
14,200
+1,800
| +15% | +$313K | 0.38% | 58 |
|
|
2022
Q3 | $2.2M | Sell |
12,400
-2,000
| -14% | -$395K | 0.36% | 59 |
|
|
2022
Q2 | $2.95M | Sell |
14,400
-1,125
| -7% | -$238K | 0.43% | 54 |
|
|
2022
Q1 | $3.69M | Sell |
15,525
-5,525
| -26% | -$1.3M | 0.45% | 52 |
|
|
2021
Q4 | $4.81M | Sell |
21,050
-5,650
| -21% | -$1.24M | 0.56% | 47 |
|
|
2021
Q3 | $5.16M | Buy |
26,700
+3,500
| +15% | +$709K | 0.64% | 43 |
|
|
2021
Q2 | $4.93M | Sell |
23,200
-4,500
| -16% | -$950K | 0.58% | 50 |
|
|
2021
Q1 | $5.66M | Sell |
27,700
-5,000
| -15% | -$985K | 0.72% | 40 |
|
|
2020
Q4 | $5.95M | Sell |
32,700
-300
| -0.9% | -$51K | 0.86% | 36 |
|
|
2020
Q3 | $5.52M | Buy |
33,000
+5,950
| +22% | +$1M | 0.92% | 31 |
|
|
2020
Q2 | $4.4M | Buy |
27,050
+7,500
| +38% | +$1.34M | 0.78% | 38 |
|
|
2020
Q1 | $3.38M | Sell |
19,550
-4,550
| -19% | -$906K | 0.75% | 32 |
|
|
2019
Q4 | $4.84M | Buy |
24,100
+3,300
| +16% | +$677K | 0.7% | 38 |
|
|
2019
Q3 | $4.4M | Sell |
20,800
-3,400
| -14% | -$710K | 0.64% | 43 |
|
|
2019
Q2 | $4.7M | Sell |
24,200
-725
| -3% | -$134K | 0.65% | 44 |
|
|
2019
Q1 | $4.1M | Buy |
24,925
+5,000
| +25% | +$884K | 0.57% | 45 |
|
|
2018
Q4 | $3.75M | Sell |
19,925
-3,425
| -15% | -$632K | 0.62% | 40 |
|
|
2018
Q3 | $3.97M | Buy |
23,350
+150
| +0.6% | +$25.3K | 0.51% | 49 |
|
|
2018
Q2 | $3.8M | Hold |
23,200
| – | – | 0.5% | 53 |
|
|
2018
Q1 | $3.75M | Hold |
23,200
| – | – | 0.49% | 52 |
|
|
2017
Q4 | $3.39M | Hold |
23,200
| – | – | 0.44% | 60 |
|
|
2017
Q3 | $3.15M | Sell |
23,200
-200
| -0.9% | -$25.3K | 0.42% | 57 |
|
|
2017
Q2 | $2.93M | Buy |
23,400
+600
| +3% | +$71.8K | 0.41% | 60 |
|
|
2017
Q1 | $2.71M | Buy |
22,800
+4,550
| +25% | +$547K | 0.37% | 65 |
|
|
2016
Q4 | $2.1M | Hold |
18,250
| – | – | 0.32% | 82 |
|
|
2016
Q3 | $1.91M | Buy |
18,250
+500
| +3% | +$52.2K | 0.3% | 82 |
|
|
2016
Q2 | $1.73M | Buy |
17,750
+10,250
| +137% | +$969K | 0.28% | 78 |
|
|
2016
Q1 | $720K | Hold |
7,500
| – | – | 0.12% | 128 |
|
|
2015
Q4 | $680K | Buy |
+7,500
| New | +$706K | 0.1% | 140 |
|
Other funds holding CME
TIM
Skylands Capital's CME Position: Q1 2025 in Review
Skylands Capital sold out of CME Group (CME) in Q1 2025, closing a stake of 1,650 shares — an estimated $383K sold.
Skylands Capital first reported a position in CME in Q4 2015 and held it in 37 quarters. The position peaked at $5.95M in Q4 2020. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.
- Skylands Capital reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
- Skylands Capital sold 1,650 CME Group shares in Q1 2025, an estimated $383K.
- Skylands Capital first reported a position in CME Group in Q4 2015 and held it in 37 quarters.
- Skylands Capital's CME Group position peaked at $5.95M in Q4 2020.
- 1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.
Based on Skylands Capital's 13F filing for Q1 2025, filed 25 Apr 2025.